spiperone has been researched along with Morphine Dependence in 9 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Morphine Dependence: Strong dependence, both physiological and emotional, upon morphine.
Excerpt | Relevance | Reference |
---|---|---|
"The effect of the chronic administration of morphine to Sprague-Dawley rats on striatal dopamine receptors labelled with [3H]spiroperidol was determined." | 1.27 | Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly). ( Bhargava, HN, 1983) |
"The effect of chronic administration of morphine to rats on 5-HT1 and 5-HT2 receptors in the cerebral cortex was determined." | 1.27 | Cerebral cortical 5-HT1 and 5-HT2 receptors of morphine tolerant-dependent rats. ( Bhargava, HN; Gulati, A, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhargava, HN | 5 |
Mennini, T | 1 |
Poggesi, E | 1 |
Cotecchia, S | 1 |
De Blasi, A | 1 |
Samanin, R | 1 |
Reddy, PL | 1 |
Thorat, SN | 1 |
Christie, MJ | 1 |
Overstreet, DH | 1 |
Puri, SK | 1 |
Spaulding, TC | 1 |
Mantione, CR | 1 |
Gulati, A | 2 |
Carlson, KR | 1 |
Cooper, DO | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Examination of Palonosetron and Hydroxyzine Pre-treatment as a Possible Method to Reduce the Objective Signs of Experimentally-induced Acute Opioid Withdrawal in Humans: a Double-blind, Randomized, Placebo-controlled Crossover Study[NCT00661674] | 10 participants (Actual) | Interventional | 2008-04-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"The OOWS is a 13-item instrument documenting physically observable signs of withdrawal, which are rated as present (1) or absent (0) during the observation period. Maximum score possible = 13, minimum score possible = 0. T=15 minutes post naloxone administration coordinates with T = 180 (min) for the entire study session.~OOWS scores at T=180 is the primary outcome measure of the study compared with baseline OOWS scores at T=-30 (30 minutes prior to study medication administration). Reported time frames are in relation to time past since administration of study medications.~Mean post-Naloxone OOWS scores (+/- SEM) were determined for pretreatment groups" (NCT00661674)
Timeframe: Change from baseline in OOWS score at 180 minutes (15 minutes post naloxone administration)
Intervention | units on a scale (OOWS Scale) (Mean) |
---|---|
Placebo | 3.5 |
Palonosetron | 1.0 |
Palonosetron + Hydroxyzine | 0 |
"The SOWS score is composed of 16 subjective symptoms rated on a scale of 0 to 4 (0=not at all, 4=extremely) based on what subjects were experiencing at the time of testing. 15 minutes post naloxone administration coordinates with T = 180 (min) for the entire study session.~The highest score possible (64) would indicate that the individual was experiencing every symptom of opioid withdrawal to the fullest extent possible while the lowest score (0) would indicate that the individual was not experiencing any symptoms of opioid withdrawal.~Mean post-naloxone SOWS scores (+/- SEM) were computed for pretreatment groups: Placebo, palonosetron, and palonosetron with hydroxyzine" (NCT00661674)
Timeframe: Change from baseline in SOWS score at 180 minutes (15 minutes post naloxone administration)
Intervention | units on a scale (SOWS Scale) (Mean) |
---|---|
Placebo | 6.0 |
Palonosetron | 4.0 |
Palonosetron + Hydroxyzine | 3.5 |
9 other studies available for spiperone and Morphine Dependence
Article | Year |
---|---|
Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
Topics: Animals; Corpus Striatum; Dipeptides; Humans; Kinetics; Male; Membranes; Morphine Dependence; MSH Re | 1983 |
Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides.
Topics: Animals; Butyrophenones; Corpus Striatum; Dipeptides; Humans; Kinetics; Male; Morphine; Morphine Dep | 1984 |
Changes in serotonin, but not catecholamine, receptor binding in the brain of morphine-dependent rats.
Topics: Animals; Brain; Carrier Proteins; Catecholamine Plasma Membrane Transport Proteins; Catecholamines; | 1981 |
Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats.
Topics: Animals; Behavior, Animal; Body Temperature; Brain Chemistry; Bromocriptine; Drug Tolerance; Kinetic | 1993 |
Sensitivity of morphine-tolerant rats to muscarinic and dopaminergic agonists: relation to tolerance or withdrawal.
Topics: Animals; Conditioning, Operant; Drug Tolerance; Humans; Male; Morphine Dependence; Parasympathomimet | 1979 |
Dopamine antagonist binding: a significant decrease with morphine dependence in the rat striatum.
Topics: Animals; Corpus Striatum; Dopamine Antagonists; Humans; Kinetics; Male; Morphine; Morphine Dependenc | 1978 |
Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats.
Topics: Animals; Brain; Drug Tolerance; Kinetics; Male; Morphine; Morphine Dependence; Rats; Rats, Inbred St | 1989 |
Morphine dependence and protracted abstinence: regional alterations in CNS radioligand binding.
Topics: Animals; Brain Chemistry; Clonidine; Dihydroalprenolol; Male; Morphine Dependence; Radioligand Assay | 1985 |
Cerebral cortical 5-HT1 and 5-HT2 receptors of morphine tolerant-dependent rats.
Topics: Animals; Cerebral Cortex; Drug Tolerance; Male; Morphine; Morphine Dependence; Pain Measurement; Rat | 1988 |